Compare Global X CleanTech (CTEC) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X CleanTech vs GeneDx Holdings Corp — how do they compare? Global X CleanTech trades at $56.36 (market cap $24.57M), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: GeneDx Holdings Corp is far larger — about 82.2× Global X CleanTech's market cap, and GeneDx Holdings Corp is more actively traded (734,640 versus 1,220). Which is the better fit depends on your goals — on Pluang, investors hold Global X CleanTech for 42 Days and GeneDx Holdings Corp for 19 Days on average.
| CTEC | WGS | |
|---|---|---|
Market Cap | $24.57M | $2.02B |
Volume | 1,220 | 734,640 |
Sector | Sector/Thematic | Health |
52-Week High | $78.11 | $167.51 |
52-Week Low | $50.82 | $34.51 |
Typical Hold Time | 42 Days | 19 Days |
Enterprise Value | — | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CTEC trades at $56.36, up 0.25% today, with a bullish technical signal from moving averages and strong trend strength (ADX 46.60). The stock faces resistance near $58 and support at $57. Key financial ratios like P/E and P/S are not provided, limiting fundamental clarity.
The outlook hinges on upcoming earnings to validate growth. Risks include opaque financials and market volatility. Analyst sentiment is mixed, with institutional interest needed to confirm the bullish technical setup.
GeneDx (WGS) trades at $67.73, down 1.17% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $454M in 2026 but faces profitability challenges with a -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth story with expanding genomic testing volumes but carries significant execution risk given negative profitability metrics. Upside potential exists if management can translate revenue growth into sustainable profits, though current cash flow trends and high valuation multiples warrant caution for risk-averse investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Global X CleanTech
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
